These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2070286)

  • 21. Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias.
    Budde T; Borggrefe M; Podczeck A; Martinez-Rubio A; Breithardt G
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):254-60. PubMed ID: 1717787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H; Baker BJ; de Soyza N; Murphy ML
    Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia.
    Morgera T; Dreas L; Humar F; Maras P; Chersevani D; Camerini F
    Int J Cardiol; 1991 May; 31(2):187-97. PubMed ID: 1869328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up.
    Guccione P; Drago F; Di Donato RM; Cicini MP; Pasquini L; Marino B; Marcelletti C; Ragonese P
    Am Heart J; 1991 Oct; 122(4 Pt 1):1022-7. PubMed ID: 1927853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.
    Yeung-Lai-Wah JA; Murdock CJ; Boone J; Kerr CR
    J Am Coll Cardiol; 1992 Sep; 20(3):547-51. PubMed ID: 1512331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of encainide for malignant ventricular arrhythmias.
    Tordjman T; Podrid PJ; Raeder E; Lown B
    Am J Cardiol; 1986 Aug; 58(5):87C-95C. PubMed ID: 3092625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant ventricular tachyarrhythmias in association with propafenone treatment.
    Buss J; Neuss H; Bilgin Y; Schlepper M
    Eur Heart J; 1985 May; 6(5):424-8. PubMed ID: 4043097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effectiveness of propafenone in congenital ectopic junctional tachycardia--a case report].
    Paul T; Reimer A; Kallfelz HC
    Z Kardiol; 1992 Sep; 81(9):482-5. PubMed ID: 1441700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propafenone in the prevention of non-ventricular arrhythmias associated with the Wolff-Parkinson-White syndrome.
    Vassiliadis I; Papoutsakis P; Kallikazaros I; Stefanadis C
    Int J Cardiol; 1990 Apr; 27(1):63-70. PubMed ID: 2335410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The efficacy and safety of intravenous propafenone in the acute treatment of spontaneous sustained ventricular tachycardia].
    Mestre JL; Moro C; Madrid AH; Novo L; Marín-Huerta E
    Rev Esp Cardiol; 1994 Jul; 47(7):461-7. PubMed ID: 8090973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of propafenone in the treatment of tachyarrhythmias in children.
    Vignati G; Mauri L; Figini A
    Eur Heart J; 1993 Apr; 14(4):546-50. PubMed ID: 8472721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study.
    Geibel A; Meinertz T; Zehender M; Vitak J; Hohnloser S; Kunz-Fritze A; Just H
    Eur Heart J; 1989 Sep; 10 Suppl E():81-7. PubMed ID: 2680506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerance of tocainide during long-term treatment of malignant ventricular arrhythmias.
    Mohiuddin SM; Esterbrooks D; Mooss AN; Dahl JM; Hilleman DE
    Clin Cardiol; 1987 Aug; 10(8):457-62. PubMed ID: 3113792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained ventricular tachycardia occurring during propafenone therapy.
    De Jaegere P; Huyghens L; Dewilde P
    Acta Cardiol; 1987; 42(3):207-12. PubMed ID: 3499736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of patients with malignant ventricular arrhythmias.
    Lown B; Graboys TB
    Am J Cardiol; 1977 May; 39(6):910-8. PubMed ID: 871114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal left ventricular function does not protect against propafenone-induced incessant ventricular tachycardia.
    Millar RN; Lawrenson JB; Milne DA
    S Afr Med J; 1993 Apr; 83(4):256-9. PubMed ID: 8316922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the rate for reaching steady state during oral propafenone therapy in patients with ventricular arrhythmias].
    Dabrowski R; Skrabucha B; Kunicki PK; Kowalik I; Skorykow-Sapińska A; Sitkiewicz D; Sadowski Z
    Pol Arch Med Wewn; 1998 Apr; 99(4):323-30. PubMed ID: 9760820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unanticipated postoperative ventricular tachyarrhythmias.
    Kron IL; DiMarco JP; Harman PK; Crosby IK; Mentzer RM; Nolan SP; Wellons HA
    Ann Thorac Surg; 1984 Oct; 38(4):317-22. PubMed ID: 6486948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanism of propafenone-induced slowing of ventricular tachycardia in man as defined by analysis of resetting response patterns.
    Callans DJ; Hook BG; Josephson ME
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):2035-41. PubMed ID: 1721220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological evaluation of moricizine in patients with sustained ventricular tachyarrhythmias: low efficacy and high incidence of proarrhythmia.
    Bhandari AK; Lerman R; Ehrlich S; Sager P; Leon C; Widerhorn J; Cannom DS
    Pacing Clin Electrophysiol; 1993 Sep; 16(9):1853-61. PubMed ID: 7692418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.